Sugarloaf Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $64.9K | Buy |
703
+48
| +7% | +$4.43K | 0.01% | 274 |
|
|
2024
Q3 | $54.9K | Hold |
655
| – | – | 0.01% | 296 |
|
|
2024
Q2 | $44.9K | Hold |
655
| – | – | 0.01% | 303 |
|
|
2024
Q1 | $48K | Hold |
655
| – | – | 0.01% | 294 |
|
|
2023
Q4 | $53.1K | Sell |
655
-926
| -59% | -$75K | 0.01% | 281 |
|
|
2023
Q3 | $118K | Buy |
1,581
+9
| +0.6% | +$674 | 0.03% | 190 |
|
|
2023
Q2 | $121K | Buy |
1,572
+10
| +0.6% | +$770 | 0.03% | 187 |
|
|
2023
Q1 | $130K | Sell |
1,562
-23
| -1% | -$1.91K | 0.03% | 177 |
|
|
2022
Q4 | $136K | Buy |
1,585
+31
| +2% | +$2.66K | 0.03% | 165 |
|
|
2022
Q3 | $96K | Sell |
1,554
-113
| -7% | -$6.98K | 0.02% | 196 |
|
|
2022
Q2 | $103K | Buy |
1,667
+11
| +0.7% | +$680 | 0.03% | 178 |
|
|
2022
Q1 | $98K | Buy |
1,656
+10
| +0.6% | +$592 | 0.02% | 190 |
|
|
2021
Q4 | $119K | Sell |
1,646
-215
| -12% | -$15.5K | 0.03% | 178 |
|
|
2021
Q3 | $130K | Sell |
1,861
-60
| -3% | -$4.19K | 0.03% | 159 |
|
|
2021
Q2 | $132K | Buy |
1,921
+144
| +8% | +$9.9K | 0.04% | 153 |
|
|
2021
Q1 | $115 | Sell |
1,777
-397
| -18% | -$26 | 0.03% | 168 |
|
|
2020
Q4 | $127K | Sell |
2,174
-174
| -7% | -$10.2K | 0.04% | 154 |
|
|
2020
Q3 | $148K | Buy |
2,348
+3
| +0.1% | +$189 | 0.05% | 128 |
|
|
2020
Q2 | $180K | Buy |
2,345
+62
| +3% | +$4.76K | 0.07% | 117 |
|
|
2020
Q1 | $171K | Buy |
2,283
+12
| +0.5% | +$899 | 0.08% | 111 |
|
|
2019
Q4 | $148K | Buy |
+2,271
| New | +$148K | 0.06% | 143 |
|